Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis.

ABSTRACT:

SUBMITTER: Rosenbaum CA 

PROVIDER: S-EPMC9631711 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature